Here is the updated edition of the Roadmap to Regenerative Medicine; the first one can be found here. Cell therapy and tissue engineering are described in more detail, than the rest of the scientific issues. I welcome everybody to take a look and add what's missing and/or change what's wrong. I'd also like to note that the organizational issues aren't described at all, but this is probably the most important part of the roadmap. There should be an implementational plan of how exactly the Roadmap should work included in the organizational part. To do that, we need to address the specialists in the given fields.
But at least for now the question is - what's missing in the scientific part?
You can download the Roadmap here.
Comments